信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·赛隆药业：子公司获得阿哌沙班化学原料药上市申请批准通知书2023-12-13 17:10:25
·诺诚健华宣布宜诺凯?（奥布替尼）新增适应症纳入2023年版国家医保药品目录2023-12-13 16:26:38
·收评：三大股指全线走低，酿酒、地产等板块下挫，医药股逆市活跃2023-12-13 16:26:31
·盘龙药业荣获两项秦药大奖2023-12-13 16:16:44
·步长制药：拟以1.80亿元-3.60亿元回购股份2023-12-13 16:11:49
·海创药业荣获中国上市公司协会“2023上市公司董办优秀实践案例”2023-12-13 14:34:23
·胖东来回应某款药品售价过高：立即停业整改2023-12-13 13:24:34
·卫材12月20日起将在日本销售阿尔茨海默症药物Leqembi2023-12-13 11:04:22
·医药行业行业研究：从生物类似物到创新分子，中国药企出海皆胜2023-12-13 10:56:22
·新版国家医保目录新增3款国产新冠治疗药物2023-12-13 10:55:58
·新冠特效药概念持续走高 拓新药业20cm涨停2023-12-13 10:21:50
·医药与健康护理行业信息点评：国产IL4R抗体国内申报上市，对标全球百亿欧元市场2023-12-13 10:13:38
·肝炎治疗拉升 双成药业涨停2023-12-13 9:59:09
·医药商业概念震荡走高 浙江震元涨停2023-12-13 9:52:09
·多普泰拟以1.9亿将所持多普泰科技27%的股权转让给西安碑林药业2023-12-12 23:18:35
·远大医药收购多普泰医药科技27%股权 加码布局心脑血管药物赛道2023-12-12 21:32:47
·创新药专题之三——高尿酸及痛风疾病专题：痛风慢病市场崛起，创新药物需求猛增2023-12-12 18:22:05
·沃华医药（002107）12月12日主力资金净卖出1606.31万元2023-12-12 17:08:41
·医药与健康护理行业信息点评：《干扰素省际联盟集中带量采购文件（征求意见稿）》发布，独家品种降幅优惠2023-12-12 17:02:29
·复星医药：控股子公司获药品注册申请受理2023-12-12 16:28:29

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]